Search results for "Hepatitis Reactivation"

showing 1 items of 1 documents

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection

2022

Background and Objective Biologics for psoriasis, especially anti-tumor necrosis factor-alpha therapies, may reactivate hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, as well in inactive carriers or patients with occult infection. However, some biologics, including anti-interleukin-17 therapies such as secukinumab, seem to be less likely to cause hepatitis reactivation. This study assessed the safety of secukinumab treatment in patients with psoriasis with HBV or HBC infection. Methods This was a retrospective cohort study of patients with moderate-to-severe psoriasis treated with secukinumab at seven Italian centers. Patients serologically positive for one or more of the fo…

Hepatitis B virusSecukinumab.HepacivirusAntibodies Monoclonal HumanizedAntiviral AgentsAntibodiesHepatitis B ChronicMonoclonalHumansPsoriasisPharmacology (medical)ViralChronicHumanizedRetrospective StudiesPsoriasiBiological ProductsHepatitis B Surface AntigensHepatitis ReactivationGeneral MedicineDNAAntibodies Monoclonal Humanized; Antiviral Agents; DNA Viral; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; RNA; Retrospective Studies; Virus Activation; Biological Products; Hepatitis B; Hepatitis B Chronic; Hepatitis C; Psoriasispsoriasis treatment secukinumab hepatitis B hepatitis CHepatitis BHepatitis CDNA ViralRNAVirus Activation
researchProduct